ACTRAPID PENFIL

About

ACTRAPID PENFIL 10S contains human insulin (soluble insulin), a short-acting insulin used for the treatment of diabetes mellitus. This formulation is designed to be administered subcutaneously, typically 15-30 minutes before a meal, to control post-meal blood glucose excursions. As a short-acting insulin, it has a rapid onset of action, usually within 30 minutes, and its peak effect occurs between 1.5 to 3.5 hours, with a total duration of action of approximately 7-8 hours. ACTRAPID is a clear solution that can also be administered intravenously in emergency situations, such as diabetic ketoacidosis or hyperosmolar hyperglycemic state. The Penfill cartridges are designed for use with compatible insulin pens, offering convenience and ease of administration for patients requiring mealtime insulin coverage or correction doses to achieve optimal glycemic control.

Uses

• Treatment of type 1 diabetes mellitus.
• Treatment of type 2 diabetes mellitus.
• Emergency treatment of diabetic ketoacidosis.
• Control of post-meal blood glucose levels.

Directions For Use

Inject subcutaneously 15-30 minutes before a meal. Rotate injection sites within the same region to prevent lipodystrophy.

Benefits

• Rapid onset of action for mealtime glucose control.
• Effective in managing postprandial hyperglycemia.
• Flexible dosing with meals.
• Well-established safety and efficacy profile.
• Can be used intravenously in emergency situations.
• Convenient Penfill cartridges for easy administration.

Side Effects

• Hypoglycemia (low blood sugar).
• Injection site reactions (pain, redness, itching, swelling).
• Lipodystrophy (fat accumulation or atrophy at injection site).
• Weight gain.
• Peripheral edema (swelling of extremities).
• Allergic reactions (rash, hives, shortness of breath).
• Pruritus (itching).
• Blurred vision (temporary, due to blood sugar changes).
• Headache.
• Flu-like symptoms.
• Antibody formation.
• Diabetic retinopathy worsening (rare).

Safety Measures

• Alcohol - Alcohol can potentiate the hypoglycemic effect of insulin; use with caution and monitor blood glucose closely.
• Pregnancy - Generally considered safe, but close monitoring and dose adjustment are crucial. Consult your doctor for personalized advice.
• Breastfeeding - Insulin is generally safe during breastfeeding, but monitor mother and infant for any adverse effects.
• Liver - Dose adjustment may be required in hepatic impairment due to altered glucose metabolism; consult your physician.
• Kidney - Dose adjustment may be required in renal impairment due to altered glucose metabolism; consult your physician.
• Lung - No specific contraindication, but general caution should be exercised in patients with severe underlying medical conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.